Samsung Electronics Posts Eightfold Profit Surge Driven by AI Chip Demand 
Pilots Fear Retaliation for Refusing Middle East Flights Amid Ongoing Conflict 
FedEx Pilots and Union Reach Tentative Agreement on 40% Pay Increase 
BHP's Incoming CEO Visits China Amid Pricing Dispute with CMRG 
China's AI Stocks Surge as Zhipu and MiniMax Hit Record Highs 
Disney Plans to Cut 1,000 Jobs Amid Ongoing Restructuring Efforts 
Lumentum Holdings Rides AI Wave With Order Book Filled Through 2028 
Bill Ackman Eyes New Fund to Bet Against Market Complacency 
Anthropic's Mythos AI Model Sparks Emergency Cybersecurity Meeting With Top U.S. Bank CEOs 
Anthropic Fights Pentagon Blacklisting in Dual Federal Court Battles 
Chalco Stock Surges as Q1 2025 Profit Forecast Jumps Up to 58% 
U.S. Automakers Push Back Against EU Rules Blocking American Trucks from European Market 
China Vanke Seeks Bond Extension Amid Mounting Debt Crisis 
Pony.ai, Uber, and Verne Launch Europe's First Commercial Robotaxi Service in Zagreb 
Apple's Foldable iPhone Faces Engineering Setbacks, Mass Production Timeline at Risk 
NIO ES9 SUV Launch Sends HK Shares Down 7% Despite Bold Pricing Strategy 
CLEVELAND, Nov. 07, 2016 -- Chart Industries, Inc. (Nasdaq:GTLS), a leading diversified global manufacturer of highly engineered equipment for the industrial gas, energy and biomedical industries, today announced an organizational realignment within its BioMedical Group to better position the company to capture future growth in the respiratory products industry.
The Group will realign a portion of its manufacturing and engineering operations and establish a Respiratory Center-of-Excellence in Canton, GA where engineering, manufacturing, sales and marketing will be centralized to jointly develop and deliver industry leading respiratory products. To realize this change, the company expects to consolidate a majority of its U.S. respiratory operation and engineering activities into the existing Canton, GA campus, relocate key personnel, and suspend production and engineering of respiratory products at its Amherst, NY facility.
“This transformation enables the company to improve collaboration and infrastructure utilization to drive product innovation, efficiency, speed, and quality,” said Earl Lawson, President of Chart BioMedical. “This realignment and our continued investment in respiratory solutions demonstrates our commitment to the industry and to improving the quality of life for millions of people suffering from COPD and other lung diseases. We are positioning the company to meet our strategic goal to have associated core engineering, manufacturing, sales and marketing resources located together to better support the growing demand for our products.”
Chart is a leading diversified global manufacturer of highly engineered equipment for the industrial gas, energy, and biomedical industries. The majority of Chart's products are used throughout the liquid gas supply chain for purification, liquefaction, distribution, storage and end-use applications. Chart has domestic operations located across the United States and an international presence in Asia, Australia, Europe and South America. For more information, visit: http://www.chartindustries.com.
Contact: Ken Webster Vice President and Chief Financial Officer 216-626-1216 [email protected]
